| Literature DB >> 28435192 |
R M Kalasariya1, A J Dhami1, K K Hadiya1, D N Borkhatariya1, J A Patel1.
Abstract
AIM: The aim of this study was to evaluate the influence of peripartum protein and minerals supplementation on plasma profile of steroid hormones, metabolites, and fertility in rural buffaloes.Entities:
Keywords: buffalo; hormone and metabolic profile; postpartum fertility; protein and mineral supplementation; transition period
Year: 2017 PMID: 28435192 PMCID: PMC5387657 DOI: 10.14202/vetworld.2017.302-310
Source DB: PubMed Journal: Vet World ISSN: 0972-8988
Figure-1Peripartum plasma progesterone profile in nutrient supplemented and control groups of buffaloes (with their micro-minerals injected and non-injected subgroups).
Figure-2Peripartum plasma estradiol 17β profile in nutrient supplemented and control groups of buffaloes (with their micro-minerals injected and non-injected subgroups).
Periparturient disorders, uterine involution, postpartum fertility and incidence of infertility in nutritionally supplemented and control groups of buffaloes.
| Puerperal events/postpartum fertility | Treatment group | Control group | ||||
|---|---|---|---|---|---|---|
| Subgroup-I (n=15) | Subgroup-II (n=25) | Pooled (n=40) | Subgroup-I (n=15) | Subgroup-II (n=30) | Pooled (n=45) | |
| Dystocia | 1 (6.67) | 1 (4.00) | 2 (5.00) | 0 (0.00) | 2 (6.67) | 2 (4.44) |
| Retention of placenta | 0 (0.00) | 2 (8.00) | 2 (5.00) | 1 (6.80) | 5 (16.70) | 6 (13.33) |
| Expulsion of placenta (h) | 2.05±0.16x | 3.93±0.52y | 3.27±0.37 | 2.79±0.42x | 5.76±0.78y | 4.44±0.53 |
| Uterine involution (d) | 28.45±0.65 | 29.90±0.67 | 29.39±0.50a | 31.54±1.28 | 32.81±0.92 | 32.12±0.82b |
| First PP estrus (d) | 62.64±1.66x | 70.40±2.22y | 67.65±1.67a | 74.69±4.36 | 82.68±4.14 | 79.43±3.06b |
| Pregnancy rate within 120 days postpartum | 10 (66.67) | 12 (48.00) | 22 (55.00) | 8 (53.33) | 10 (33.33) | 18 (40.00) |
| Service period (d) | 85.60±8.07 | 96.18±5.90 | 90.89±4.41a | 91.25±7.19x | 116.43±4.08y | 105.09±4.76b |
| Number of services per conception | 1.36 | 1.85 | 1.58 | 1.89 | 2.67 | 2.28 |
| Overall infertility | 5 (33.33) | 12 (52.00) | 17 (45.00) | 7 (46.67) | 17 (66.67) | 24 (60.00) |
| True anestrus | 1 (6.67) | 3 (12.00) | 4 (10.00) | 2 (13.33) | 6 (20.00) | 8 (17.78) |
| Subestrus | 3 (20.00) | 7 (28.00) | 10 (25.00) | 3 (20.00) | 8 (26.27) | 11 (24.44) |
| Repeat breeder | 1 (6.67) | 2 (8.00) | 3 (7.50) | 2 (13.33) | 3 (10.00) | 5 (11.11) |
Subgroup-I=Stimvet 5 ml i/m, Subgroup-II=Stimvet control. Figures in parentheses indicate percentage values. Means bearing different superscripts within the row differ significantly between groups (a, b) or sub-groups (x, y) within the group (p<0.05)
Mean plasma progesterone concentrations during peripartum period in buffaloes under nutrients supplemented and control groups and subgroups.
| Days peripartum | Plasma progesterone concentration (ng/ml) | |||||
|---|---|---|---|---|---|---|
| Treatment group | Control group | |||||
| Subgroup-I (n=9) | Subgroup-II (n=9) | Pooled (n=18) | Subgroup-I (n=7) | Subgroup-II (n=7) | Pooled (n=14) | |
| −60 | 4.60±0.16c | 4.66±0.16c | 4.63±0.11e | 4.67±0.19c | 4.76±0.11d | 4.72±0.11d |
| −30 | 4.28±0.14c | 4.24±0.18c | 4.26±0.11de | 4.43±0.19c | 4.54±0.27cd | 4.49±0.16cd |
| −15 | 4.02±0.07c | 4.00±0.14c | 4.01±0.14d | 4.29±0.16c | 3.81±0.24c | 4.05±0.15c |
| 0 | 0.54±0.07a | 0.50±0.06ab | 0.52±0.05ab | 0.42±0.10a | 0.46±0.06ab | 0.44±0.06a |
| 15 | 0.35±0.06a | 0.28±0.05a | 0.31±0.04a | 0.31±0.07a | 0.25±0.03a | 0.28±0.04a |
| 30 | 0.76±0.31a | 0.70±0.27ab | 0.73±0.20ab | 0.43±0.14a | 0.63±0.17ab | 0.53±0.11a |
| 45 | 1.00±0.22a | 0.79±0.29ab | 0.90p±0.18b | 1.43±0.51b | 1.04±0.34ab | 1.23q±0.30b |
| 60 | 1.73±0.48b | 1.06±0.45b | 1.40±0.33c | 0.98±0.39ab | 1.26±0.68b | 1.12±0.38b |
Subgroup-I=Micro-minerals 5 ml i/m, Subgroup-II=Micro-minerals control, Day 0=Day of calving. Means bearing uncommon superscripts within the column (abcde) differ significantly between periods and those within the row (pq) differ significantly between pooled values (p<0.05)
Mean plasma estradiol-17β concentrations during peripartum period in buffaloes under nutrients supplemented and control groups and subgroups.
| Days perpartum | Plasma estradiol-17β concentration (pg/ml) | |||||
|---|---|---|---|---|---|---|
| Treatment group | Control group | |||||
| Subgroup-I (n=9) | Subgroup-II (n=9) | Pooled (n=18) | Subgroup-I (n=7) | Subgroup-II (n=7) | Pooled (n=14) | |
| −60 | 44.33±4.23b | 46.00±2.57c | 45.17±2.41c | 45.71±2.44c | 48.86±3.34b | 47.29±2.03b |
| −30 | 54.78±4.77c | 57.02±3.51d | 55.89±2.89d | 55.14±2.31d | 56.71±3.39b | 55.93±1.98c |
| −15 | 76.67±4.04d | 76.44±3.42e | 76.56±2.57e | 72.43±1.53e | 71.00±3.56c | 71.71±1.87d |
| 0 | 143.11±4.55e | 146.56±5.00f | 144.83±3.31f | 147.71±3.93f | 145.56±6.24d | 146.79±3.55e |
| 15 | 19.89±2.54a | 21.33±2.89a | 20.61±1.87a | 20.86±1.65a | 21.29±2.37a | 21.07±1.39a |
| 30 | 25.33±1.94a | 25.67±1.79ab | 25.50±1.28ab | 29.00x±1.53b | 21.00y±2.02a | 25.00±1.65a |
| 45 | 28.33±3.07a | 32.89±2.97b | 30.61±2.15b | 25.86±2.55ab | 20.57±1.23a | 23.21±1.54a |
| 60 | 29.00±3.22a | 27.11±3.49ab | 28.06±2.32b | 27.71±3.95ab | 22.57±2.62a | 25.14±2.39a |
Subgroup-I=Micro-minerals 5 ml i/m, Subgroup-II=Micro-minerals control, Day 0=Day of calving. Means bearing uncommon superscripts within the column (abcdef) differ significantly between periods and those within the row (xy) differ significantly between sub-groups (p<0.05)
Mean blood glucose levels during peripartum period in buffaloes under nutrients supplemented and control groups and subgroups.
| Days pre-and postpartum | Blood glucose levels (mg/dl) | |||||
|---|---|---|---|---|---|---|
| Treatment group | Control group | |||||
| Subgroup-I (n=9) | Subgroup-II (n=9) | Pooled (n=18) | Subgroup-I (n=7) | Subgroup-II (n=7) | Pooled (n=14) | |
| −60 | 45.89±1.88a | 47.67±2.10a | 46.28±1.41a | 45.86±1.35a | 45.29±1.13a | 45.57±0.87a |
| −30 | 46.67±1.175ab | 49.11±2.12a | 47.89±1.36ab | 47.29±3.46a | 46.86±2.15a | 47.07±1.96ab |
| −15 | 44.78±1.84ax | 51.67±2.73ay | 48.22±1.80abc | 47.57±3.19a | 48.43±2.70a | 48.00±2.01ab |
| 0 | 55.78±2.05d | 61.67±2.65b | 58.72±1.78e | 60.29±3.97b | 56.43±3.09b | 58.36±2.48c |
| 15 | 49.00x±1.39abc | 54.78y±1.86a | 51.89±1.33bcd | 51.43±3.29a | 50.14±2.56ab | 50.79±2.01b |
| 30 | 52.78±1.37cd | 52.33±1.54a | 52.56p±1.00cd | 50.14±2.58a | 46.57±1.93a | 48.36q±1.62ab |
| 45 | 52.56±1.67cd | 53.22±1.81a | 52.89p±1.20d | 47.00±1.75a | 48.00±1.89a | 47.50q±1.24ab |
| 60 | 51.67±2.77bcd | 52.22±2.53a | 51.94±1.82bcd | 51.00±2.05a | 50.14±2.01ab | 50.57±1.38b |
| Overall | 49.76x±0.78 | 52.83y±0.88 | 51.30p±0.60 | 49.82±1.12 | 48.98±0.86 | 49.40q±0.71 |
Subgroup-I=Micro-minerals 5 ml i/m, Subgroup-II=Micro-minerals control, Day 0=Day of calving. Means bearing uncommon superscripts within the column (abcd) differ significantly between periods and those within the row (xy) differ significantly between sub-groups and between groups (pq) (p<0.05)
Mean plasma total protein levels during peripartum period in buffaloes under nutrients supplemented and control groups and subgroups.
| Days pre-and postpartum | Plasma total protein levels (g/dl) | |||||
|---|---|---|---|---|---|---|
| Treatment group | Control group | |||||
| Subgroup-I (n=9) | Subgroup-II (n=9) | Pooled (n=18) | Subgroup-I (n=7) | Subgroup-II (n=7) | Pooled (n=14) | |
| −60 | 7.77±0.18ab | 7.66±0.11b | 7.72±0.10bc | 7.81±0.24 | 7.65±0.16ab | 7.73±0.14ab |
| −30 | 8.16±0.16b | 7.94±0.12b | 8.05±0.10c | 7.74±0.25 | 7.87±0.27b | 7.81±0.18b |
| −15 | 8.00±0.20ab | 7.76±0.22b | 7.88±0.15b | 7.75±0.21 | 7.51±0.12ab | 7.63±0.12ab |
| 0 | 7.26±0.32a | 7.35±0.13a | 7.31±0.17a | 7.53±0.16 | 7.04±0.20a | 7.29±0.14a |
| 15 | 7.63±0.21ab | 7.80±0.04b | 7.72±0.11b | 7.72x±0.12 | 7.07y±0.09a | 7.41±0.12ab |
| 30 | 7.58x±0.17ab | 8.08y±0.10b | 7.83p±0.12bc | 7.63±0.12 | 7.14±0.24a | 7.38q±0.15ab |
| 45 | 7.90±0.33ab | 7.81±0.19b | 7.86±0.19bc | 7.76±0.07 | 7.32±0.20ab | 7.54±0.12ab |
| 60 | 7.82±0.21ab | 7.93±0.09b | 7.87p±0.11bc | 7.74±0.16 | 7.19±0.23a | 7.47q±0.16ab |
| Overall | 7.83±0.09 | 7.85±0.05 | 7.84p±0.05 | 7.71x±0.06 | 7.35y±0.08 | 7.53q±0.05 |
Subgroup-I=Micro-minerals 5 ml i/m, Subgroup-II=Micro-minerals control, Day 0=Day of calving. Means bearing uncommon superscripts within the column differ significantly between periods (abc) and those within the row differ between sub-groups (xy) or groups (pq) (p<0.05)
Mean plasma total cholesterol levels during peripartum period in buffaloes under nutrients supplemented and control groups and subgroups.
| Days pre-and postpartum | Plasma total cholesterol concentration (mg/dl) | |||||
|---|---|---|---|---|---|---|
| Treatment group | Control group | |||||
| Subgroup-I (n=9) | Subgroup-II (n=9) | Pooled (n=18) | Subgroup-I (n=7) | Subgroup-II (n=7) | Pooled (n=14) | |
| −60 | 62.14±5.45b | 63.18±5.72bc | 62.64±3.84cd | 69.55±6.44b | 67.12±6.52c | 68.33±4.45d |
| −30 | 54.89±4.20ab | 56.57±5.97abc | 55.73p±3.15bc | 66.35±4.42b | 64.29±4.98bc | 65.32q±3.24cd |
| −15 | 51.23±3.58ab | 52.66±7.12ab | 51.95±3.87ab | 57.86±5.34ab | 57.21±6.70abc | 57.53±4.12bc |
| 0 | 43.24±3.29a | 42.27±5.26a | 42.76±3.01a | 46.51±2.08a | 45.82±4.64a | 46.17±2.45a |
| 15 | 50.04±5.09ab | 47.41±3.13ab | 48.73±3.02ab | 57.05±3.37ab | 50.15±3.05ab | 53.60±2.39ab |
| 30 | 55.24±6.26ab | 58.10±3.33bc | 56.67±3.46bcd | 61.18±3.41ab | 51.25±3.44ab | 56.21±2.70bc |
| 45 | 58.70±4.04b | 68.71±4.15c | 63.71±3.06cd | 62.28±5.64ab | 56.40±2.79abc | 59.34±3.13bcd |
| 60 | 63.69±2.47b | 68.72±4.76c | 66.27±2.27d | 66.71±7.38b | 57.72±1.69abc | 62.22±3.84bcd |
| Overall | 54.15±1.65 | 56.45±1.98 | 55.30p±1.29 | 61.44x±1.94 | 56.25y±1.75 | 58.84q±1.32 |
Subgroup-I=Micro-minerals 5 ml i/m, Subgroup-II=Micro-minerals control, Day 0=Day of calving. Means bearing uncommon superscripts within the column differ significantly between periods (abcd) and those within the row differ between subgroups (xy) or groups (pq) (p<0.05)
Mean plasma triglycerides levels during peripartum period in buffaloes under nutrients supplemented and control groups and subgroups.
| Days pre-and postpartum | Plasma triglycerides levels (mg/dl) | |||||
|---|---|---|---|---|---|---|
| Treatment group | Control group | |||||
| Subgroup-I (n=9) | Subgroup-II (n=9) | Pooled (n=18) | Subgroup-I (n=7) | Subgroup-II (n=7) | Pooled (n=14) | |
| −60 | 24.57±2.59b | 23.69±2.96b | 24.13±1.91c | 23.20±3.14b | 23.19±1.82c | 23.20±1.74c |
| −30 | 25.47±3.19b | 22.99±2.57b | 24.23±2.01c | 21.81±2.05ab | 21.14±1.59bc | 21.48±1.25bc |
| −15 | 24.84±2.58b | 20.50±1.93ab | 22.67±1.65bc | 19.73±2.54ab | 20.67±2.43bc | 20.20±1.69bc |
| 0 | 14.46±1.97a | 12.84±1.94a | 13.65±1.35a | 12.62±2.92a | 13.15±1.44a | 12.88±1.56a |
| 15 | 19.26±1.96ab | 14.59±2.41a | 16.93±1.61a | 15.70±2.47ab | 16.38±2.51ab | 16.04±1.69ab |
| 30 | 18.55±2.60ab | 17.57±2.10ab | 18.06±1.62ab | 18.50±4.01ab | 15.99±1.95ab | 17.24±2.72ab |
| 45 | 17.98±2.64ab | 16.05±2.64ab | 17.01±1.83a | 17.20±3.55ab | 16.56±2.62ab | 16.88±2.12ab |
| 60 | 18.46±2.02ab | 17.48±2.50ab | 17.97±1.57ab | 18.61±3.60ab | 15.09±1.78ab | 16.85±1.99ab |
| Overall | 20.45±0.94 | 18.21±0.92 | 19.33±0.66 | 18.42±1.11 | 17.77±0.81 | 18.10±0.68 |
Subgroup-I=Micro-minerals 5 ml i/m, Subgroup-II=Micro-minerals control, Day 0=Day of calving. Means bearing uncommon superscripts within the column (abc) differ significantly between periods (p<0.05)
| Chelated mineral mixture (%) | Compounded concentrate (%) | ||
|---|---|---|---|
| Calcium | 20.00 | Maize | 11.00 |
| Phosphorus | 12.00 | Molasses | 10.00 |
| Sulphur | 2.00 | Soya bean | 17.50 |
| Zinc | 2.25 | De-oiled rice bran | 56.50 |
| Manganese | 0.12 | Mineral mixture | 2.00 |
| Cobalt | 0.014 | Salt | 1.00 |
| Copper | 0.20 | Urea | 1.00 |
| Iodine | 0.030 | Bypass fat | 1.00 |